<!DOCTYPE html>
<html lang="en">
<head>

<title>Cephalosporins: Four Generations of Beta-Lactam Antibiotics </title>
  <meta charset="utf-8">
  
  <link href="urology.css" rel="stylesheet">

<meta name="keywords" content="cephalosporins, " >
<meta name="description" content="Cephalosporins are an important group of &beta;-lactame antibiotics, which are grouped in four generations with different antibiotic spectrums, from the online textbook of urology by D. Manski" >
<meta name="author" content="Dr. med. Dirk Manski" >
<meta name="copyright" content="Dirk Manski" >
<meta name="robots" content="index">
<meta name="robots" content="follow">
<meta name="viewport" content="width=device-width, initial-scale=1">
<script type="text/javascript" src="https://steadyhq.com/widget_loader/d07e8b63-2cb6-4caa-8cd8-ac224b34b49f"></script></head>

<body><script src="https://consent.cookiefirst.com/banner.js" data-cookiefirst-key="37f6f6c6-5bff-4142-be7d-7a354b5345de"></script>
<header>
    <a class="ribbon" tabindex="-1" title="back to start!" href="https://www.urology-textbook.com/index.html">
	   <h5 id="logo">urology-textbook.com</h5>
       <p>Dr. med. Dirk Manski</p>
    </a>  
</header>
<main>
<nav id="navigation">
<ul>
<li><a href="https://www.urology-textbook.com/index.html">Start</a></li>
<li><a href="https://www.urology-textbook.com/anatomy.html">Anatomy</a></li>
<li><a href="https://www.urology-textbook.com/signs-and-symptoms.html">Signs and Symptoms</a></li>
<li><a href="https://www.urology-textbook.com/examinations.html">Examinations</a></li>
<li><a href="https://www.urology-textbook.com/surgical-management.html">Surgical Management</a></li>
<li><a href="https://www.urology-textbook.com/pharmacology.html">Pharmacology</a></li>
<li><a href="https://www.urology-textbook.com/kidneys.html">Kidneys</a></li>
<li><a href="https://www.urology-textbook.com/ureters.html">Ureters</a></li>
<li><a href="https://www.urology-textbook.com/bladder.html">Bladder</a></li>
<li><a href="https://www.urology-textbook.com/prostate.html">Prostate</a></li>
<li><a href="https://www.urology-textbook.com/urethra.html">Urethra</a></li>
<li><a href="https://www.urology-textbook.com/penis.html">Penis</a></li>
<li><a href="https://www.urology-textbook.com/testes.html">Testes</a></li>
<li><a href="https://www.urology-textbook.com/adrenal-glands.html">Adrenal Glands</a></li>
<li><a href="https://www.urology-textbook.com/common-diseases.html">Common Diseases</a></li>
<li><a href="https://www.urology-textbook.com/urologic-surgery.html">Urologic Surgery</a></li>
<li><a href="https://www.urology-textbook.com/index-urology.html">Index</a></li>
<li><a href="https://www.urology-textbook.com/medical-abbreviations.html">Abbreviations</a></li>
<li><a href="https://www.urology-textbook.com/urology-news.html">News</a></li>
<li><a href="https://www.urology-textbook.com/links.html">Links</a></li>
</ul>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<script type="steady-switch" data-when="no-subscription"><!-- 
<ins class="adsbygoogle"
     style="display:block"
     data-ad-client="ca-pub-9284927104423861"
     data-ad-slot="3282433998"
     data-ad-format="auto"
     data-full-width-responsive="true"></ins>
<script>
     (adsbygoogle = window.adsbygoogle || []).push({});
</script>
--></script>
</nav>
<article>
<br>
<script type="steady-switch" data-when="no-subscription"><!-- 
<ins class="adsbygoogle"
     style="display:block"
     data-ad-client="ca-pub-9284927104423861"
     data-ad-slot="8643406037"
     data-ad-format="auto"
     data-full-width-responsive="true"></ins>
<script>
     (adsbygoogle = window.adsbygoogle || []).push({});
</script>
--></script>
<br>
<p id="brotkrumen">&nbsp;You are here: <a href="https://www.urology-textbook.com/index.html">Urology Textbook</a> &gt; <a href="https://www.urology-textbook.com/pharmacology.html">Drugs in Urology</a> &gt; Cephalosporins</p><!-- Main content -->

<h1>Cephalosporins: Four Generations of Beta-Lactam Antibiotics</h1><p>Review literature: (<a HREF="#SimonStille1997">Simon and Stille, 1997</a>).</p>

<h2>Four Generation of Cephalosporins</h2>

<p>Cephalosporins are &beta;-lactam antibiotics, which are grouped into four generations according to their antibiotic spectrum of activity. The first generation has mainly gram-positive activity. The second and third generation has more gram-negative activity with mostly decreased activity against gram-positive bacteria. The fourth generation of cephalosporins has a broad spectrum activity. The following list provides an overview over the generations of cephalosporins with major substances:</p><ul title="generations of cephalosporins">
<li>First Generation: cefazolin, cefalexin, cefadroxil</li>
<li>Second Generation: cefamandole, cefoxitin, cefaclor, cefuroxime, loracarbef, cefotetan</li>
<li>Third generation: cefotaxime, cefpodoxime, ceftizoxime, ceftriaxone, ceftazidime, cefoperazone
</li>
<li>Fourth generation: cefepime, cefozopran, cefpirome, cefquinome
</li>
</ul>

<br>

<a name="cefazolin"></a>
<h2>Cefazolin</h2><h3>Antibiotic Spectrum of Cefazolin</h3> 

<p>Cefazolin is a first-generation cephalosporin. Cefazolin has a comparable antibiotic spectrum as penicillin. In addition, cefazolin has activity against gram-negative bacteria (E. coli, Klebsiella) and staphylococci.</p>

<h3>Urologic Indications for Cefazolin</h3> 

<ul title="urologic indications for cefazolin" type="disc">
<li>Staphylococci infections</li>
<li>Wound infections</li>
<li>Perioperative antibiotic prophylaxis</li>
<li>Cefazolin can replace penicillin in a penicillin allergy. Patients with penicillin allergy have a low risk of cross-allergy (10%), which is even lower with cephalosporines of the second and third generation.</li>
</ul><h3>Pharmacokinetics of Cefazolin</h3> 

<p>Cefazolin is only for parenteral administration available. Elimination half life 1.5 h, 90% renal elimination.</p>

<h3>Side Effects of Cefazolin</h3>

<ul title="side effects of cefazolin">
<li>Allergy: 1&ndash;4%. Normally, there is a small risk for cross-allergy to penicillin (10%)
</li>
<li>Allergic neutropenia</li>
<li>Positive direct Coombs test, very rarely hemolytic anemia.</li>
<li>Inhibiting the effect of anticoagulants or antiplatelet agents</li>
</ul>

<h3>Contraindications of Cefazolin</h3> 

<p>Cephalosporin allergy. </p>

<h3>Dosage of Cefazolin</h3> 

<p>In adults, the dosage of cefazolin is 1 g 1-1-1 i.v. Children receive a daily dose of 60&nbsp;mg/kg body weight, divided in three doses. Dose reduction is necessary in renal insufficiency. </p>

<a name="cefuroxime"></a>
<h2>Second Generation of Cephalosporins</h2>

<p>Cefuroxime, cefotiam and cefaclor are important substances of the second generation of Cephalosporins. </p>

<h3>Antibiotic Spectrum of Second Generation Cephalosporins</h3>
<p>Good activity against streptococci, gonococci, meningococci, Haemophilus and staphylococci. High &beta;-lactamase resistance. No efficacy against Pseudomonas, enterococci, mycoplasma, chlamydia. </p>

<h3>Urologic Indications of Cefuroxime:</h3> 

<ul title="urologic indications for cefuroxime" type="disc">
<li><a href="https://www.urology-textbook.com/urinary-tract-infection.html">Urinary tract infection</a></li>
<li>Treatment of <a href="https://www.urology-textbook.com/gonorrhea.html">gonorrhea</a></li>
<li>Staphylococci infections</li>
<li>Wound infection</li>
<li>Perioperative antibiotic prophylaxis</li>
<li>Cefuroxime can replace penicillin in a penicillin allergy. </li>
</ul>

<h3>Pharmacokinetics of Cefuroxime and Cefotiam</h3> 

<p>Cefuroxime can be applied per os or intravenously. Elimination half life 1 h. 70&ndash;90% renal elimination.</p><h3>Side Effects of Cefuroxime</h3>

<ul title="side effects of cefuroxim">
<li>Allergy: 1&ndash;4%. There is a minimal risk for cross-allergy to penicillin.</li>
<li>Allergic neutropenia</li>
<li>Positive direct Coombs test, very rarely hemolytic anemia.</li>
<li>Inhibiting the effect of anticoagulants or antiplatelet agents</li>
</ul>

<h3>Contraindications of Cefuroxime</h3> 

Cephalosporin allergy.

<h3>Dosage of Cefuroxime and Cefotiam</h3> 

<p>In urinary tract infections: cefuroxime 250&ndash;500&nbsp;mg 1-1-1 p.o., 750&nbsp;mg 1-1-1 i.v. or 1 g cefotiam 1-1-1 i.v., depending on severity of infection <a HREF="#Ovalle2000">Ovalle et al. 2000</a>. Children receive 25&nbsp;mg/kg i.v. 1-1-1. In severe infections the dosage is doubled. Dose reduction is necessary in renal insufficiency.</p>

<a name="ceftriaxone"></a>
<h2>Third Generation of Cephalosporins</h2>

<p>Important substances of third-generation cephalosporins are cefotaxime and ceftriaxone (cefotaxime-group).</p>

<h3>Antibacterial Spectrum of cefotaxime and ceftriaxone</h3> 

<p>Cefotaxime and Ceftriaxone show good activity against streptococci, gonococci, meningococci, Haemophilus and staphylococci. High &beta;-lactamase resistance. Weak activity against Pseudomonas. No activity against enterococci, mycoplasma, chlamydia and multidrug-resistant Staphylococcus aureus.</p>

<h3>Urologic Indications for Third Generation Cephalosporins</h3> <ul title="urologic indications for third generation cephalosporins">
<li>Severe urinary tract infections, can be combined with gentamicin to include enterococci</li>
<li>Severe postoperative infections like peritonitis</li>
<li>Treatment of gonorrhea with a single dose of ceftriaxone i.m.</li>
</ul><br>



<h3>Pharmacokinetics of Cefotaxime and Ceftriaxone</h3> 

<p>Only parenteral administration of cefotaxime and ceftriaxone is possible. The elimination half life is 1&nbsp;h for cefotaxime and 7&ndash;8&nbsp;h for ceftriaxone. 50% renal elimination.
</p>

<h3>Side Effects of Cefotaxime and Ceftriaxone</h3>
 
<ul title="side effects of cefotaxime and ceftriaxone">
<li>Allergy: 1&ndash;4%. There is a minimal risk for cross-allergy to penicillin.
</li>
<li>Allergic neutropenia</li>
<li>Positive direct Coombs test, very rarely hemolytic anemia.</li>
<li>Inhibition of the efficacy of anticoagulants or antiplatelet agents</li>
<li>Alcohol intolerance possible</li>
</ul>

<h3>Contraindications</h3> 

Cephalosporin allergy.<h3>Dosage of Cefotaxime and Ceftriaxone</h3> 

<p><i>Treatment of severe infection:</i> the daily dosage of cefotaxime in adults amounts to 3&ndash;6 g (children 50&ndash;100&nbsp;mg/kg), depending on the severity of the infection, and is divided into three doses. The daily dosage for ceftriaxone is 2&ndash;4 g in two doses. Dose reduction is necessary with a renal insufficiency below a <a href="https://www.urology-textbook.com/kidney-glomerular-filtration-rate.html">glomerular filtration rate</a> of 5 ml/min.</p><p><i>Single shot treatment of gonorrhea:</i> 250&nbsp;mg ceftriaxone i.m. [see Chapter <a href="https://www.urology-textbook.com/gonorrhea.html">gonorrhea</a>].
</p>

<h2>Oral Cephalosporins</h2>
<a name="ceftibuten"></a>
<h3>Ceftibuten</h3>

<p>
Ceftibuten is an oral cephalosporin which a high activity against Enterobacteriaceae and is suitable for the treatment of severe or complicated urinary tract infection in children 
<a HREF="#Ho2001">Ho et al, 2001</a> <a HREF="#Vilaichone2001">Vilaichone et al, 2001</a>.
</p>

<h4>Pharmacokinetics of Ceftibuten:</h4> <p>Elimination half life 2.5 h. 70% renal elimination.</p>

<h4>Dosage of Ceftibuten:</h4> <p>400&nbsp;mg 1-0-0 in adults, 9&nbsp;mg/kg body weight 1-0-0 in children.</p>

<h3>Cefixime</h3>
<a name="cefixime"></a>
<p>Cefixime is a derivative of cefotaxime, which can be given orally. Cefixime is suitable for the treatment of urinary tract infection in children <a href="#Gok2001">Gok et al, 2001</a> <a HREF="#Ho2001">Ho et al, 2001</a>.</p>

<h4>Pharmacokinetics of Cefixime:</h4> <p>Elimination half life 2.5 h, only 20% renal elimination, high biliary excretion.</p>

<h4>Dosage of Cefixime:</h4> <p>Adults 200&nbsp;mg 1-0-1 or 400&nbsp;mg 1-0-0 p.o., children 4&nbsp;mg/kg body weight 1-0-1 or 8&nbsp;mg/kg 1-0-0. </p>

<a name="cefpodoxime"></a>
<h3>Cefpodoxime</h3>

<p>
Cefpodoxime is a derivative of ceftizoxime. Cefpodoxime is suitable for the oral treatment of urinary tract infections.</p>

<h4>Pharmacokinetics of cefpodoxime:</h4> Elimination half life 2.5 h, 30&ndash;40% renal elimination.<h4>Dosage of cefpodoxime:</h4> <p>Adults 200&nbsp;mg 1-0-1 and children 4&nbsp;mg/kg body weight 1-0-1.</p>

<br>
<br>

<table  id="navigation_unten">
<tr>
 
<td><a href="https://www.urology-textbook.com/surgical-management.html">Surgical management</a></td>
<td><a class="nav4" href="https://www.urology-textbook.com/index-urology.html">Index</a></td>
<td><a class="nav3" href="https://www.urology-textbook.com/pharmacology.html">Pharmacology</a></td>
 
</tr>
</table>
<br><br>

<script type="steady-switch" data-when="no-subscription"><!-- 
<ins class="adsbygoogle"
     style="display:block"
     data-ad-client="ca-pub-9284927104423861"
     data-ad-slot="8643406037"
     data-ad-format="auto"
     data-full-width-responsive="true"></ins>
<script>
     (adsbygoogle = window.adsbygoogle || []).push({});
</script>
--></script>
<br>
<br>
Index: <a href="https://www.urology-textbook.com/index-urology-a.html">1&ndash;9</a> <a href="https://www.urology-textbook.com/index-urology-a.html">A</a> <a href="https://www.urology-textbook.com/index-urology-b.html">B</a> <a href="https://www.urology-textbook.com/index-urology-c.html">C</a> <a href="https://www.urology-textbook.com/index-urology-d.html">D</a> <a href="https://www.urology-textbook.com/index-urology-e.html">E</a> <a href="https://www.urology-textbook.com/index-urology-f.html">F</a> <a href="https://www.urology-textbook.com/index-urology-g.html">G</a> <a href="https://www.urology-textbook.com/index-urology-h.html">H</a> <a href="https://www.urology-textbook.com/index-urology-i.html">I</a> <a href="https://www.urology-textbook.com/index-urology-j.html">J</a> <a href="https://www.urology-textbook.com/index-urology-k.html">K</a> <a href="https://www.urology-textbook.com/index-urology-l.html">L</a> <a href="https://www.urology-textbook.com/index-urology-m.html">M</a> <a href="https://www.urology-textbook.com/index-urology-n.html">N</a> <a href="https://www.urology-textbook.com/index-urology-o.html">O</a> <a href="https://www.urology-textbook.com/index-urology-p.html">P</a> <a href="https://www.urology-textbook.com/index-urology-q.html">Q</a> <a href="https://www.urology-textbook.com/index-urology-r.html">R</a> <a href="https://www.urology-textbook.com/index-urology-s.html">S</a> <a href="https://www.urology-textbook.com/index-urology-t.html">T</a> <a href="https://www.urology-textbook.com/index-urology-u.html">U</a> <a href="https://www.urology-textbook.com/index-urology-v.html">V</a> <a href="https://www.urology-textbook.com/index-urology-w.html">W</a> <a href="https://www.urology-textbook.com/index-urology-xyz.html">X Y Z</a> 

<br>
<br>
<br>
<hr><h3>References</h3>

<dl>
<dt><a NAME="Gok2001">
Gok u.a. 2001 G<SMALL>OK</SMALL>, F.&nbsp;; D<SMALL>UZOVA</SMALL>, A.&nbsp;;
  B<SMALL>ASKIN</SMALL>, E.&nbsp;; O<SMALL>ZEN</SMALL>, S.&nbsp;; B<SMALL>ESBAS</SMALL>, N.&nbsp;;
  B<SMALL>AKKALOGLU</SMALL>, A.:
</a>
<dd> Comparative study of cefixime alone versus intramuscular ceftizoxime
  followed by cefixime in the treatment of urinary tract infections in
  children.
<br> In: <I>J Chemother</I>
<br> 13 (2001), Nr.&nbsp;3, S.&nbsp;277&ndash;80

<br>
<p>
<dt><a NAME="Ho2001">
Ho u.a. 2001 H<SMALL>O</SMALL>, M.&nbsp;W.&nbsp;; W<SMALL>ANG</SMALL>, F.&nbsp;D.&nbsp;;
  F<SMALL>UNG</SMALL>, C.&nbsp;P.&nbsp;; L<SMALL>IU</SMALL>, C.&nbsp;Y.:
</a>
<dd> Comparative study of ceftibuten and cefixime in the treatment of
  complicated urinary tract infections.
<br> In: <I>J Microbiol Immunol Infect</I>
<br> 34 (2001), Nr.&nbsp;3, S.&nbsp;185&ndash;9

<br>
<p>
<dt><a NAME="Ovalle2000">
Ovalle u.a. 2000 O<SMALL>VALLE</SMALL>, A.&nbsp;; M<SMALL>ARTINEZ</SMALL>,
  M.&nbsp;A.&nbsp;; W<SMALL>OLFF</SMALL>, M.&nbsp;; C<SMALL>ONA</SMALL>, E.&nbsp;; V<SMALL>ALDERRAMA</SMALL>, O.&nbsp;;
  V<SMALL>ILLABLANCA</SMALL>, E.&nbsp;; L<SMALL>OBOS</SMALL>, L.:
</a>
<dd> [Prospective, randomized, comparative study of the efficacy, safety
  and cost of cefuroxime versus cephradine in <a href="https://www.urology-textbook.com/acute-pyelonephritis.html">acute pyelonephritis</a> during pregnancy].
<br> In: <I>Rev Med Chil</I>
<br> 128 (2000), Nr.&nbsp;7, S.&nbsp;749&ndash;57

<br>
<p>
<dt><a NAME="SimonStille1997">
Simon und Stille 1997 S<SMALL>IMON</SMALL>, C.&nbsp;; S<SMALL>TILLE</SMALL>, W.:
</a>
<dd> <I>Antibiotika-Therapie in Klinik und Praxis</I>.
<br> 9. Auflage.
<br> Stuttgart New York&nbsp;: Schattauer, 1997

<br>
<p>
<dt><a NAME="Vilaichone2001">
Vilaichone u.a. 2001 V<SMALL>ILAICHONE</SMALL>, A.&nbsp;; W<SMALL>ATANA</SMALL>,
  D.&nbsp;; C<SMALL>HAIWATANARAT</SMALL>, T.:
</a>
<dd> Oral ceftibuten switch therapy for acute pyelonephritis in children.
<br> In: <I>J Med Assoc Thai</I>
<br> 84 Suppl 1 (2001), S.&nbsp;S61&ndash;7
</dl><br>
<br>
<p><img src="https://images.urology-textbook.com/deutsch.gif">&nbsp; Deutsche Version: <a href="https://www.urologielehrbuch.de/cephalosporine.html">Cephalosporine</a></p>
<br>
</article>
</main>
<footer class="grid">
    <ul id="footer-nav">
    		<li>Copyright by Dr. med. Dirk Manski </li>
		<li><a href="https://www.urology-textbook.com/privacy-policy.html">Privacy policy</a></li>
		<li><a href="https://www.urology-textbook.com/disclaimer.html">Disclaimer</a></li>
	</ul>
	
	<img src="https://images.urology-textbook.com/https://vg08.met.vgwort.de/na/15fcbea3018d4a7dad12c35297d4de58" width="1" height="1" alt="">
<script defer src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
</footer>
</body>
</html>
